# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-109828
Filing Date
2025-11-12
Accepted
2025-11-12 08:16:27
Documents
74
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tmb-20250930x10q.htm iXBRL | 10-Q | 1841573
2 | EX-31.1 | tmb-20250930xex31d1.htm | EX-31.1 | 15611
3 | EX-32.1 | tmb-20250930xex32d1.htm | EX-32.1 | 7531
4 | GRAPHIC | tmb-20250930x10q001.jpg | GRAPHIC | 40869
| Complete submission text file | 0001104659-25-109828.txt |  | 7744092

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | tmb-20250930.xsd | EX-101.SCH | 59338
6 | EX-101.CAL | tmb-20250930_cal.xml | EX-101.CAL | 57242
7 | EX-101.DEF | tmb-20250930_def.xml | EX-101.DEF | 197032
8 | EX-101.LAB | tmb-20250930_lab.xml | EX-101.LAB | 493415
9 | EX-101.PRE | tmb-20250930_pre.xml | EX-101.PRE | 359575
77 | EXTRACTED XBRL INSTANCE DOCUMENT | tmb-20250930x10q_htm.xml | XML | 1250752

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 251469186
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)